Trial intelligence / Profile preview

Population Pharmacokinetics of Meropenem in Critically Ill Infant Patients

TCTR20191106001Recruiting

Sponsor
The 90th Anniversary of Chulalongkorn University Fund
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of meropenem in bacterial disease, sponsored by The 90th Anniversary of Chulalongkorn University Fund. Primary endpoint: Population pharmacokinetic parameters of meropenem. Started Feb 2020; status: recruiting.

02

Drugs

meropenem
03

Conditions

bacterial disease

Beyond the preview

Go deeper on TCTR20191106001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20191106001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call